<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635802</url>
  </required_header>
  <id_info>
    <org_study_id>zdyfysicu-1</org_study_id>
    <nct_id>NCT02635802</nct_id>
  </id_info>
  <brief_title>the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation</brief_title>
  <official_title>the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yichang Humanwell Pharmaceutical Co.,Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The First Affiliated Hospital of Zhengzhou University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remifentanil is one kind of opiates with strong analgesic effect,which has the rapid onset
      and short lasting duration. Remifentanil usually is used to help reducing the pain of
      patients with mechanical ventilation in ICU. Maybe it can also be used to ease the pain in
      ICU small short time operation.The purpose of this study is to determine (1) whether
      remifentanil is effective in small short time operations in ICU or not, (2) the save range of
      remifentanil in small short time operations in ICU, (3) and the adverse reaction that happens
      in these operations.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>heart rate, respiration rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>respiration rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>blood oxygen saturation of artery blood of finger(SpO2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>mean blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>Critical-Care Observation Tool(CPOT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vital signs change</measure>
    <time_frame>baseline, intraoperative and 10mins after operation</time_frame>
    <description>Richmond Agitation-Sedation Scale(RASS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of adverse reaction</measure>
    <time_frame>baseline,intraoperative,10mins after operation,30mins after operation</time_frame>
    <description>respiratory depression,skeletal muscle stiffness,nausea vomting and dizziness,hypertension,allergy,bradycardia etc.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Remifentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection form concentration 20μg/ml loading dose 1.0-2.0μg/kg intravenous injection slowly,time ＞1min,then 5μg/kg·h pumping until the operation is finished.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection form concentration 10mg/ml loading dose 100-400mg local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil+Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection form concentration 20μg/ml loading dose 1.0-2.0μg/kg intravenous injection slowly,time ＞1min,then 5μg/kg·h pumping until the operation is finished
+ injection form concentration 10mg/ml loading dose 100-400mg local anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>a loading dose 1.0-2.0μg/kg remifentanil,intravenous injection slowly,time ＞1min,then 5μg/kg·h pumping if the operation can not be done in 5 minutes.
Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after the loading.We should maintain the CPOT≤2 and RASS 0～2,if it is not up to the standard,increasing the pumping rate 0.5 μg/kg·h every 2-5min.</description>
    <arm_group_label>Remifentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>lidocaine 100-400mg,local anesthesia.Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after local anesthesia.We should maintain the CPOT≤2 and RASS 0～2.</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil+Lidocaine</intervention_name>
    <description>a loading dose 1.0-2.0μg/kg remifentanil,intravenous injection slowly,time ＞1min,then 5μg/kg·h remifentanil pumping immediately if the operation can not be done in 5 minutes.then local anesthesia with lidocaine 100-400mg.Critical-Care Observation Tool(CPOT) and Richmond Agitation-Sedation Scale(RASS) are assessed before and after anesthesia.We should maintain the CPOT≤2 and RASS 0～2,if it is not up to the standard,increasing the pumping rate 0.5μg/kg·h every 2-5min.</description>
    <arm_group_label>Remifentanil+Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>midazolam is an adjuvant drug.we should maintain the CPOT≤2 and RASS 0～2,if lidocaine is already used up to 400mg or the pumping rate of remifentanil is already 7.5μg/kg·h,then we should use midazolam 3mg, intravenous injection slowly.</description>
    <arm_group_label>Remifentanil</arm_group_label>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_label>Remifentanil+Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  critically ill patients need endotracheal intubation

          -  tracheotomy

          -  central venous puncture

          -  pleural puncture

          -  abdominal puncture

          -  lumbar puncture

          -  bone marrow puncture

          -  fiber bronchoscopic examination

          -  other small short-time operations

        Exclusion Criteria:

          -  patients allergic to opioids

          -  in pregnancy or in feeding

          -  with myasthenia gravis

          -  with hypovolemia,

          -  take monoamine oxidase inhibitor(MAOI) in 14days

          -  in coma and GCS＜8

          -  with bradycardia or hypotension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Evane TN, Park GR. Remifentanil in the critically ill. Anaesthesia. 1997 Aug;52(8):800-1.</citation>
    <PMID>9291773</PMID>
  </results_reference>
  <results_reference>
    <citation>Soltész S, Biedler A, Silomon M, Schöpflin I, Molter GP. Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery. Br J Anaesth. 2001 Jun;86(6):763-8.</citation>
    <PMID>11573581</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilhelm W, Dorscheid E, Schlaich N, Niederprüm P, Deller D. [The use of remifentanil in critically ill patients. Clinical findings and early experience]. Anaesthesist. 1999 Sep;48(9):625-9. German.</citation>
    <PMID>10525595</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilhelm W, Kreuer S. The place for short-acting opioids: special emphasis on remifentanil. Crit Care. 2008;12 Suppl 3:S5. doi: 10.1186/cc6152. Epub 2008 May 14. Review.</citation>
    <PMID>18495056</PMID>
  </results_reference>
  <results_reference>
    <citation>Casey E, Lane A, Kuriakose D, McGeary S, Hayes N, Phelan D, Buggy D. Bolus remifentanil for chest drain removal in ICU: a randomized double-blind comparison of three modes of analgesia in post-cardiac surgical patients. Intensive Care Med. 2010 Aug;36(8):1380-5. doi: 10.1007/s00134-010-1836-2. Epub 2010 Mar 18.</citation>
    <PMID>20237760</PMID>
  </results_reference>
  <results_reference>
    <citation>Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med. 2013 Jan;39(1):53-8. doi: 10.1007/s00134-012-2697-7. Epub 2012 Sep 28.</citation>
    <PMID>23052952</PMID>
  </results_reference>
  <results_reference>
    <citation>Al MJ, Hakkaart L, Tan SS, Bakker J. Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Crit Care. 2010;14(6):R195. doi: 10.1186/cc9313. Epub 2010 Nov 1.</citation>
    <PMID>21040558</PMID>
  </results_reference>
  <results_reference>
    <citation>Futier E, Chanques G, Cayot Constantin S, Vernis L, Barres A, Guerin R, Chartier C, Perbet S, Petit A, Jabaudon M, Bazin JE, Constantin JM. Influence of opioid choice on mechanical ventilation duration and ICU length of stay. Minerva Anestesiol. 2012 Jan;78(1):46-53. Epub 2011 Nov 5.</citation>
    <PMID>21971434</PMID>
  </results_reference>
  <results_reference>
    <citation>Battershill AJ, Keating GM. Remifentanil : a review of its analgesic and sedative use in the intensive care unit. Drugs. 2006;66(3):365-85. Review.</citation>
    <PMID>16526829</PMID>
  </results_reference>
  <results_reference>
    <citation>Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B, Kirkham AJ. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care. 2004 Aug;8(4):R268-80. Epub 2004 Jun 28.</citation>
    <PMID>15312228</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2015</study_first_submitted>
  <study_first_submitted_qc>December 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2015</study_first_posted>
  <last_update_submitted>December 16, 2015</last_update_submitted>
  <last_update_submitted_qc>December 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Zhengzhou University</investigator_affiliation>
    <investigator_full_name>Rongqi Sun</investigator_full_name>
    <investigator_title>The director of SICU,Chief physician,professor</investigator_title>
  </responsible_party>
  <keyword>remifentanil</keyword>
  <keyword>analgesia</keyword>
  <keyword>intensive care units</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

